Inovio Pharma (INO) Reports Interim Phase 1 Data For INO-4800 Vaccine for COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) | Delayed: 1.04 +0.05 (5.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.99 | 52 Week High | $11.69 | |||
| Open | $0.96 | 52 Week Low | $4.50 | |||
| Day High | $1.06 | P/E | N/A | |||
| Day Low | $0.96 | EPS | $-0.28 | |||
| Volume | 1,758,376 | |||||
